These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9269999

  • 1. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 2. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
    Shapiro GI, Koestner DA, Matranga CB, Rollins BJ.
    Clin Cancer Res; 1999 Oct 15; 5(10):2925-38. PubMed ID: 10537362
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T, Chen B, Warrier A, Medina DJ, Moore D, Bertino JR.
    Clin Cancer Res; 2009 Feb 15; 15(4):1232-40. PubMed ID: 19174488
    [Abstract] [Full Text] [Related]

  • 7. Flavopiridol binds to duplex DNA.
    Bible KC, Bible RH, Kottke TJ, Svingen PA, Xu K, Pang YP, Hajdu E, Kaufmann SH.
    Cancer Res; 2000 May 01; 60(9):2419-28. PubMed ID: 10811119
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M, Benzo A, Irrissuto C, Lopez G, Curatella B, Maggi CA, Manzini S, Crea A, Caroli S, Cubadda F, Binaschi M.
    Cancer Chemother Pharmacol; 2008 Sep 01; 62(4):621-9. PubMed ID: 18038274
    [Abstract] [Full Text] [Related]

  • 11. Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
    Bible KC, Boerner SA, Kirkland K, Anderl KL, Bartelt D, Svingen PA, Kottke TJ, Lee YK, Eckdahl S, Stalboerger PG, Jenkins RB, Kaufmann SH.
    Clin Cancer Res; 2000 Feb 01; 6(2):661-70. PubMed ID: 10690552
    [Abstract] [Full Text] [Related]

  • 12. Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells.
    Liebmann JE, Fisher J, Teague D, Cook JA.
    Oncol Res; 1994 Feb 01; 6(1):25-31. PubMed ID: 7919549
    [Abstract] [Full Text] [Related]

  • 13. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C, Motwani M, Kortmansky J, Sirotnak FM, She Y, Gonen M, Haimovitz-Friedman A, Schwartz GK.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.
    Albain KS, Swinnen LJ, Erickson LC, Stiff PJ, Fisher SG, Fisher RI.
    Semin Oncol; 1992 Jun 01; 19(3 Suppl 9):102-9. PubMed ID: 1641650
    [Abstract] [Full Text] [Related]

  • 15. Synergistic antitumor effect of chemotherapy and antisense-mediated ablation of the cell cycle inhibitor p27KIP-1.
    Achenbach TV, Müller R, Slater EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3006-14. PubMed ID: 10955778
    [Abstract] [Full Text] [Related]

  • 16. Flavopiridol sensitivity of cancer cells isolated from ascites and pleural fluids.
    Richard C, Matthews D, Duivenvoorden W, Yau J, Wright PS, Th'ng JP.
    Clin Cancer Res; 2005 May 01; 11(9):3523-9. PubMed ID: 15867255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antagonistic interplay between antimitotic and G1-S arresting agents observed in experimental combination therapy.
    Johnson KR, Young KK, Fan W.
    Clin Cancer Res; 1999 Sep 01; 5(9):2559-65. PubMed ID: 10499633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.